LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	41.05	35.14	44.44	18.31
Short-Term Investments	176.06	30.65	-	-
Cash & Short-Term Investments	217.11	65.79	44.44	18.31
Cash Growth	146.28%	48.05%	142.75%	-
Prepaid Expenses	3.48	1.45	2.2	0.02
Total Current Assets	220.7	67.24	46.64	18.32
Property, Plant & Equipment	1.91	0.37	0.28	0.01
Long-Term Deferred Charges	-	2.74	-	-
Other Long-Term Assets	1.4	0.02	0.03	0
Total Assets	224.01	70.38	46.95	18.34
Accounts Payable	2.76	5.71	4.76	0.46
Accrued Expenses	4.32	12.67	4.29	0.79
Current Portion of Leases	0.63	0.14	0.1	-
Current Income Taxes Payable	-	-	0.35	-
Total Current Liabilities	7.71	18.51	9.5	1.25
Long-Term Leases	0.95	0.19	0.15	-
Other Long-Term Liabilities	0.06	0.12	0.07	-
Total Liabilities	8.73	18.83	9.71	1.25
Common Stock	-	5.91	5.91	5.9
Additional Paid-In Capital	347.12	2.52	1.1	0.25
Retained Earnings	-132.36	-95.25	-25.28	-14.47
Comprehensive Income & Other	0.52	0.01	-	-
Total Common Equity	215.28	-86.81	-18.27	-8.31
Shareholders' Equity	215.28	51.55	37.24	17.08
Total Liabilities & Equity	224.01	70.38	46.95	18.34
Total Debt	1.58	0.33	0.25	-
Net Cash (Debt)	215.53	65.47	44.19	18.31
Net Cash Growth	145.50%	48.14%	141.39%	-
Net Cash Per Share	9.53	6.76	4.67	1.96
Filing Date Shares Outstanding	27.5	25.53	9.63	9.36
Total Common Shares Outstanding	27.5	9.74	9.63	9.36
Working Capital	212.99	48.73	37.14	17.07
Book Value Per Share	7.83	-8.91	-1.90	-0.89
Tangible Book Value	215.28	-86.81	-18.27	-8.31
Tangible Book Value Per Share	7.83	-8.91	-1.90	-0.89
Machinery	-	0.07	0.05	0.02
Leasehold Improvements	-	0.01	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.